Macular Degeneration Treatment Market is expected to reach US$ 15.7 billion by 2033 | Major players - Novartis AG, Genentech USA, Inc., REGENXBIO Inc., F Hoffmann-La Roche Ltd.

Market Size and Growth:

The Macular Degeneration Treatment Market size reached US$ 9.8 billion in 2024 and is expected to reach US$ 15.7 billion by 2033, growing at a CAGR of 5.26% during the forecast period 2025-2033.

The Macular Degeneration Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/macular-degeneration-treatment-market?sz

The Macular Degeneration Treatment Market comprises pharmaceuticals, biologics, gene and cell therapies, devices, and supportive services aimed at preventing vision loss and restoring retinal function in age-related and inherited macular disorders. It includes anti-VEGF agents, sustained-release implants, laser and surgical options, diagnostics, and distribution channels, driven by aging populations, innovation, reimbursement, and expanding access across hospitals, clinics, and centers worldwide.

Recent Key Developments of United States:

✅ December 2025: Major investment announced in AI-driven early detection tools, partnering with tech firms to integrate into routine screenings.

✅ November 2025: Clinical trial results showed promising efficacy of a gene therapy targeting dry AMD complement pathway, advancing phase 3 studies.

✅ October 2025: FDA approved a novel sustained-release anti-VEGF implant for wet AMD, reducing injection frequency for patients.

Recent Key Developments of Japan:

✅ December 2025: National screening initiative launched using AI diagnostics, targeting urban centers like Tokyo for early intervention.

✅ November 2025: iPS cell-derived retinal therapy entered late-stage trials, focusing on wet AMD regeneration in collaboration with local biotech.

✅ October 2025: Approval of long-acting aflibercept biosimilar expanded treatment access amid rising AMD cases in aging population.

List of the Key Players in the Macular Degeneration Treatment Market:

Novartis AG
Regeneron Pharmaceuticals Inc.
Genentech USA, Inc.
REGENXBIO Inc.
Bausch Health Companies Inc.
F Hoffmann-La Roche Ltd.
Santen Pharmaceutical Co., Ltd.
GNH Pharmaceuticals USA LLC
Iveric Bio Inc.
Allergan Inc.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/macular-degeneration-treatment-market?sz

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Segments Covered in the Macular Degeneration Treatment Market:

By Type: Wet Macular Degeneration, Dry Macular Degeneration.

By Treatment: Drugs, Therapy, Surgery, Others.

By End-User: Hospitals, Ambulatory Surgical Centers, Ophthalmic Clinics, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=macular-degeneration-treatment-market

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Macular Degeneration Treatment market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Macular Degeneration Treatment Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Macular Degeneration Treatment market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Macular Degeneration Treatment Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Macular Degeneration Treatment Market in 2025?
◆ What is the projected growth rate of the Macular Degeneration Treatment Market through 2033?
◆ Who are the key players in the Macular Degeneration Treatment Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.